DRTS
Alpha Tau Medical Ltd
NASDAQ: DRTS · HEALTHCARE · BIOTECHNOLOGY
$13.35
-1.18% today
Updated 2026-10-28
Market cap
$1.21B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$3 – $16
Volume
0.5M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$8.67
-35.06%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.34x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -1.47 — distress zone
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.0B |
| Net income | $-33.76M | $-29.16M | $-31.75M | $-42.63M | $-45.81M | — |
| EPS | — | — | — | — | $-1.04 | $-0.52 |
| Free cash flow | $-24.78M | $-24.36M | $-22.02M | $-32.76M | — | — |
| Profit margin | — | — | — | — | — | — |
Peer comparison
Smart narrative
Alpha Tau Medical Ltd trades at $13.35. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -1.47, it sits in the distress.
Frequently asked questions
What is Alpha Tau Medical Ltd's stock price?
Alpha Tau Medical Ltd (DRTS) trades at $13.35.
Is Alpha Tau Medical Ltd overvalued?
Alpha Tau Medical Ltd carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Alpha Tau Medical Ltd (DRTS)?
The 12-month analyst consensus target is $8.67, about 35.1% below the current $13.35. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of DRTS by 2030?
Our research-backed model puts the 2030 base case at $27.23, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
Altman Z-Score?
Alpha Tau Medical Ltd's Altman Z-Score is -1.47, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-82.01%
Beta1.22
50D MA$14.43
200D MA$10.33
Shares out0.09B
Float0.06B
Short ratio—
Avg volume0.5M
Performance
1 week+14.49%
1 month+3.60%
3 months+58.70%
YTD+126.67%
1 year—
3 years—
5 years—